1. Lcb01-0371
1. 1219707-39-7
2. Lcb01-0371
3. Lcb-01-0371
4. Lcb-010371
5. 43ep6xv33e
6. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
7. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one
8. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
9. (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
10. 2-oxazolidinone, 3-(4-(5,6-dihydro-1-methyl-1,2,4-triazin-4(1h)-yl)-3-fluorophenyl)-5-(hydroxymethyl)-, (5r)-
11. Unii-43ep6xv33e
12. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
13. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)oxazolidin-2-one
14. Delpazolid [inn]
15. Delpazolid [who-dd]
16. Delpazolid (lcb01-0371)
17. Chembl1673408
18. Schembl11969210
19. Gtpl10999
20. Bcp25650
21. Ex-a1715
22. Db13077
23. Lcb-01,0371
24. Ac-33876
25. Hy-100180
26. Cs-0018175
27. Q27258646
Molecular Weight | 308.31 g/mol |
---|---|
Molecular Formula | C14H17FN4O3 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 308.12846858 g/mol |
Monoisotopic Mass | 308.12846858 g/mol |
Topological Polar Surface Area | 68.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 450 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)